Level Biotechnology Inc. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was TWD 151.64 million compared to TWD 182.34 million a year ago. Net income was TWD 16.83 million compared to TWD 15.64 million a year ago. Basic earnings per share from continuing operations was TWD 0.52 compared to TWD 0.48 a year ago. Diluted earnings per share from continuing operations was TWD 0.52 compared to TWD 0.48 a year ago.
For the six months, sales was TWD 268.28 million compared to TWD 344.36 million a year ago. Net income was TWD 27.81 million compared to TWD 34.03 million a year ago. Basic earnings per share from continuing operations was TWD 0.86 compared to TWD 1.05 a year ago. Diluted earnings per share from continuing operations was TWD 0.85 compared to TWD 1.04 a year ago.